Zobrazeno 1 - 10
of 58 847
pro vyhledávání: '"Diabetes Mellitus"'
Autor:
Zay Htet, Mahzuz Karim
Publikováno v:
Journal of the Royal Society of Medicine. 114(7)
Recent years have seen a paradigm shift in the management of patients with diabetes mellitus. Rather than good glycaemic control being the sole primary aim, the therapeutic focus has broadened to consider potential additional cardiovascular and renal
Autor:
Alyaa Hasan Bohan, Noor Thair Tahir, Teba Daud Soluiman, Ashwak Jasim Kzar Shammari, Rasha Kareem Hashim
Publikováno v:
Materials Today: Proceedings. 80:3082-3085
A major consequence of diabetes (type 2) is diabetic nephropathy and its leading cause of chronic kidney disease. This study was amid to determination of insulin like growth factor −1 in diabetic nephropathy patients and its relation with other bio
Autor:
Lesley A. Inker, Hiddo J.L. Heerspink, Tord Rikte, Shira Perl, Sapphire investigators, Tom Greene, Vlado Perkovic, Magnus K. Bjursell, Fredrik Erlandsson, Robert Terkeltaub, Austin G. Stack
Publikováno v:
Nephrology Dialysis Transplantation, 37(8), 1461-1471. Oxford University Press
Background Verinurad is a human uric acid (UA) transporter (URAT1) inhibitor known to decrease serum UA (sUA) levels and that may reduce albuminuria. In a Phase 2a study (NCT03118739), treatment with verinurad + febuxostat lowered urine albumin-to-cr
Publikováno v:
Gait & Posture. 95:242-248
Background Diabetic retinopathy is a principal cause of visual damage and blindness, in which laser treatment offers proven therapy. The progressive degeneration of the retina, secondary to diabetes, is believed to cause postural instability although
Autor:
Moamen Mostafa Asla, Hoda M. Adayel, Aml M. Brakat, Aya Y. Aboalfetoh, Marwa Abdelazim Rizk, Ibrahim Abdelmonaem Abdelhaleem
Publikováno v:
Medicina Clínica (English Edition). 158:576-585
Type 2 diabetes mellitus (T2DM) is a progressive meta-inflammatory disorder, which induce micro and macrovascular complications. Resveratrol is a nutraceutical known to have antioxidant and anti-inflammatory properties. It improves insulin resistance
Autor:
Joanna Parkinson, David W. Boulton, Weifeng Tang, Robert C. Penland, Bengt Hamrén, Melin J, Dinko Rekić
Publikováno v:
The Journal of Clinical Pharmacology. 62:1227-1235
Aim: Dapagliflozin improves glycaemic control in patients with type 2 diabetes mellitus (T2DM) and is approved in European and Japanese patients with type 1 diabetes mellitus (T1DM) with inadequate glycaemic control. The objectives of this work were
Autor:
Ema Aoki, Toshiyuki Hayashi, Rieko Kodera, Shinji Koba, Mitsuru Hosoya, Noriyuki Satoh, Takeshi Hirashima, Yasuki Ito, Motoko Ohta, Tsutomu Hirano, Natsuko Suzuki, Taito Oshima
Publikováno v:
Journal of Atherosclerosis and Thrombosis. 29:762-774
Aims Abnormal compositional changes in low-density lipoprotein (LDL) particles, such as triglyceride (TG) enrichment and size reduction, are common in patients with diabetes. Several cohort studies have demonstrated that LDL-TG and sdLDL-cholesterol
Publikováno v:
Mini-Reviews in Medicinal Chemistry. 22:1341-1350
Abstract: Hyperglycemia and its associated disorders like Diabetes mellitus are engulfing the world’s population at a faster pace. New-age medications like the SGLT 2 inhibitors have found their place in the run to combat DM. Drugs with these prope
Publikováno v:
Antioxidants & Redox Signaling. 36:608-630
Significance: Diabetic heart disease (DHD) is the primary cause of mortality in people with diabetes. A significant contributor to the development of DHD is the disruption of redox balance due to r...
Publikováno v:
Diabetes Technology & Therapeutics. 24:281-284
Real-time continuous glucose monitoring (RT-CGM) is superior to blood glucose monitoring (BGM) for adults with insulin-treated type 2 diabetes (T2D); however, the utility of C-peptide levels for predicting the magnitude of the glycemic benefits is co